Joel Sunshine

5.6k total citations · 1 hit paper
58 papers, 2.9k citations indexed

About

Joel Sunshine is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Joel Sunshine has authored 58 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 25 papers in Oncology and 12 papers in Immunology. Recurrent topics in Joel Sunshine's work include RNA Interference and Gene Delivery (15 papers), Advanced biosensing and bioanalysis techniques (12 papers) and CAR-T cell therapy research (11 papers). Joel Sunshine is often cited by papers focused on RNA Interference and Gene Delivery (15 papers), Advanced biosensing and bioanalysis techniques (12 papers) and CAR-T cell therapy research (11 papers). Joel Sunshine collaborates with scholars based in United States, Russia and South Korea. Joel Sunshine's co-authors include Jordan J. Green, Janis M. Taube, Karlo Perica, Jonathan P. Schneck, Randall A. Meyer, Róbert Langer, Daniel G. Anderson, Stephany Y. Tzeng, Drew M. Pardoll and Jae‐Seung Lee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Advanced Materials.

In The Last Decade

Joel Sunshine

54 papers receiving 2.9k citations

Hit Papers

PD-1/PD-L1 inhibitors 2015 2026 2018 2022 2015 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joel Sunshine United States 24 1.5k 1.0k 887 556 405 58 2.9k
Maciej S. Lesniak United States 21 717 0.5× 534 0.5× 491 0.6× 394 0.7× 372 0.9× 36 1.8k
Mariangela Figini Italy 28 999 0.6× 1.3k 1.3× 683 0.8× 526 0.9× 218 0.5× 66 2.6k
Shu Wang Singapore 31 1.4k 0.9× 856 0.8× 865 1.0× 611 1.1× 696 1.7× 69 3.3k
Heather E. Fleming United States 26 1.8k 1.2× 601 0.6× 970 1.1× 625 1.1× 112 0.3× 42 4.0k
Shuji Ozaki Japan 30 1.4k 0.9× 1.4k 1.4× 681 0.8× 542 1.0× 396 1.0× 134 3.6k
Pauline Chu United States 22 1.5k 1.0× 544 0.5× 336 0.4× 816 1.5× 316 0.8× 29 3.1k
Yiran Zheng China 21 1.1k 0.7× 959 0.9× 1.4k 1.6× 1.4k 2.4× 686 1.7× 43 3.0k
Rachel Riley United States 19 1.7k 1.1× 925 0.9× 1.2k 1.3× 1.5k 2.7× 734 1.8× 26 3.8k
Jurjen Tel Netherlands 35 1.1k 0.7× 1.1k 1.0× 2.4k 2.7× 865 1.6× 290 0.7× 73 3.8k
Albert Lo United States 17 1.0k 0.7× 2.0k 1.9× 801 0.9× 620 1.1× 154 0.4× 18 2.8k

Countries citing papers authored by Joel Sunshine

Since Specialization
Citations

This map shows the geographic impact of Joel Sunshine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Sunshine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Sunshine more than expected).

Fields of papers citing papers by Joel Sunshine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel Sunshine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Sunshine. The network helps show where Joel Sunshine may publish in the future.

Co-authorship network of co-authors of Joel Sunshine

This figure shows the co-authorship network connecting the top 25 collaborators of Joel Sunshine. A scholar is included among the top collaborators of Joel Sunshine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joel Sunshine. Joel Sunshine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Charles, et al.. (2025). Spatial proteomics for investigating solid tumor resistance mechanisms. Cancer and Metastasis Reviews. 44(4). 76–76.
2.
Tripathi, Raghav, et al.. (2025). Racial disparities in the diagnosis and treatment of dermatofibrosarcoma protuberans. Journal of the American Academy of Dermatology. 93(3). 775–777.
3.
Sunshine, Joel, et al.. (2025). An analysis of the impact of program signals and geographic preferences on interview invites for the dermatology match process. Journal of the American Academy of Dermatology. 93(2). 546–547.
4.
Luly, Kathryn M, et al.. (2024). Efficient Polymeric Nanoparticle Gene Delivery Enabled Via Tri- and Tetrafunctional Branching. Biomacromolecules. 25(11). 7260–7273. 1 indexed citations
5.
Sunshine, Joel, et al.. (2024). Cutaneous Presentation of Xylazine-Associated Wounds. 5(5). 1 indexed citations
6.
Luly, Kathryn M, Jordan J. Green, Joel Sunshine, & Stephany Y. Tzeng. (2023). Biomaterial-Mediated Genetic Reprogramming of Merkel Cell Carcinoma and Melanoma Leads to Targeted Cancer Cell Killing In Vitro and In Vivo. ACS Biomaterials Science & Engineering. 9(11). 6438–6450. 4 indexed citations
7.
Green, Benjamin, Margaret Eminizer, Steve Lu, et al.. (2023). Whole-Slide Imaging, Mutual Information Registration for Multiplex Immunohistochemistry and Immunofluorescence. Laboratory Investigation. 103(8). 100175–100175. 4 indexed citations
8.
Gordy, James T., Kun Luo, Samuel K. Ayeh, et al.. (2023). IFNα and 5-Aza-2’-deoxycytidine combined with a dendritic-cell targeting DNA vaccine alter tumor immune cell infiltration in the B16F10 melanoma model. Frontiers in Immunology. 13. 1074644–1074644. 10 indexed citations
9.
Jedrych, Jaroslaw, et al.. (2022). Calciphylaxis Cutis Associated With Fibroblast Growth Factor Receptor (FGFR) Inhibitor Therapy: A New Challenge. Cureus. 14(1). e21478–e21478. 5 indexed citations
10.
Kim, Jayoung, et al.. (2021). High-throughput evaluation of polymeric nanoparticles for tissue-targeted gene expression using barcoded plasmid DNA. Journal of Controlled Release. 337. 105–116. 29 indexed citations
11.
Sunshine, Joel, et al.. (2020). Postherpes zoster programmed death-1 inhibitor−associated zosteriform granulomatous reactions. JAAD Case Reports. 6(12). 1201–1204. 3 indexed citations
12.
Gerami, Pedram, Daniel Kim, Bin Zhang, et al.. (2020). Clinical, morphologic, and genomic findings in ROS1 fusion Spitz neoplasms. Modern Pathology. 34(2). 348–357. 31 indexed citations
13.
Meyer, Randall A., Mohit P. Mathew, Elana Ben‐Akiva, et al.. (2018). Anisotropic biodegradable lipid coated particles for spatially dynamic protein presentation. Acta Biomaterialia. 72. 228–238. 23 indexed citations
14.
Sunshine, Joel, Nadine S. Jahchan, Julien Sage, & Jaehyuk Choi. (2018). Are there multiple cells of origin of Merkel cell carcinoma?. Oncogene. 37(11). 1409–1416. 87 indexed citations
15.
Sunshine, Joel, Peter Nguyen, Genevieve J. Kaunitz, et al.. (2017). PD-L1 Expression in Melanoma: A Quantitative Immunohistochemical Antibody Comparison. Clinical Cancer Research. 23(16). 4938–4944. 109 indexed citations
16.
Sunshine, Joel, Karlo Perica, Jonathan P. Schneck, & Jordan J. Green. (2013). Particle shape dependence of CD8+ T cell activation by artificial antigen presenting cells. Biomaterials. 35(1). 269–277. 213 indexed citations
17.
Shmueli, Ron B., Joel Sunshine, Zhenhua Xu, Elia J. Duh, & Jordan J. Green. (2012). Gene delivery nanoparticles specific for human microvasculature and macrovasculature. Nanomedicine Nanotechnology Biology and Medicine. 8(7). 1200–1207. 40 indexed citations
18.
Sunshine, Joel, Sarah B. Sunshine, Imran Ahmed Bhutto, James T. Handa, & Jordan J. Green. (2012). Poly(β-Amino Ester)-Nanoparticle Mediated Transfection of Retinal Pigment Epithelial Cells In Vitro and In Vivo. PLoS ONE. 7(5). e37543–e37543. 81 indexed citations
19.
Sunshine, Sarah B., Joel Sunshine, Marisol Cano, Jordan J. Green, & James T. Handa. (2011). Nitric Oxide Induces Nrf2 Signaling In RPE Cells In Vitro. Investigative Ophthalmology & Visual Science. 52(14). 2345–2345. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026